Management Team
ABOUT US
Jay Kranzler, MD, PhD
Chairman and Chief Executive Officer
- 24 years as CEO of 2 public companies (with 2 rheumatology product approvals), and most recently led Pfizer’s External R&D Innovation group and R&D Innovate venture fund
- Founding member of McKinsey & Company’s Pharmaceutical Practice
- Professor at NYU Medical & Business schools
- Founder, Board Member, and Advisor to an extensive number of companies and institutions
- Received his MD and PhD (pharmacology) from Yale University
Scott Baumgartner, MD
Interim Chief Medical Officer
- Experienced clinical development and medical affairs expert
- Previously VP of Medical Affairs at AstraZeneca/Ardea Biosciences and Amgen
- Experience in the clinical development and post-launch activities of Lesinurad and Verinurad
- Received medical degree from University of Washington; has practiced rheumatology for ~20 years